<html>
        <head>
            <link rel="stylesheet" type="text/css" href="layout.css" />
        </head>
        <style> 
            .right { 
                margin-left: 160px;
            } 
        </style>
        
        <div class="sidenav">
            <a href="about.html">About</a>
            <a href="index.html">Index</a>
        </div>
    <div class="header"><h3>MADIT-II</h3></div><p><span class="main">"Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction". The New England Journal of Medicine. 2002. 346(12):877-883. </span></p><p><span class="contents">
                                        Links to original sources:
                                        <a href=https://www.wikijournalclub.org//wiki/MADIT-II>Wiki Journal Post</a>
                                        <a href=http://www.nejm.org/doi/full/10.1056/NEJMoa013474>Full Journal Article</a>
                                        </span></p><p><span class="main">Contents
1 Clinical Question
2 Bottom Line
3 Major Points
4 Guidelines
5 Design
6 Population
6.1 Inclusion Criteria
6.2 Exclusion Criteria
6.3 Baseline Characteristics
7 Interventions 
8 Outcomes
8.1 Primary Outcome
9 Criticisms
10 Funding
11 Further Reading
 </span></p><h2><span class="labels">Clinical Question</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Does prophylactic implantation of a defibrillator improve survival among patients with a prior myocardial infarction and reduced left ventricular ejection fraction?
 </span></p><h2><span class="labels">Bottom Line</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Prophylactic implantation of a defibrillator in patients with prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less improves survival.
 </span></p><h2><span class="labels">Major Points</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Implantable defibrillators have been known to improve survival in high-risk patients, but previous studies required invasive electrophysiological testing. The Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) sought to evaluate the benefit of prophylactic defibrillators without the need for such testing in patients with a prior myocardial infarction and advanced left ventricular dysfunction.
 </span></p><h2><span class="labels">Guidelines</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Patients who fit the MADIT-II profile (prior MI and EF ≤30%) are generally recommended to consider prophylactic implantation of a defibrillator.
 </span></p><h2><span class="labels">Design</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Multicenter, randomized controlled trial
- N=1232 patients with prior MI and ejection fraction ≤0.30
- Intervention: Implantable defibrillator (n=742)
- Control: Conventional medical therapy (n=490)
- Primary outcome: Death from any cause
- Follow-up: Average of 20 months
 </span></p><h2><span class="labels">Population</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Inclusion Criteria
- Prior myocardial infarction
- Left ventricular ejection fraction ≤0.30
 </span></p><p><span class="main">Exclusion Criteria
- Contraindications for defibrillator
- Recent MI or revascularization
- Advanced non-cardiac diseases
 </span></p><p><span class="main">Baseline Characteristics
- Similar between groups
- Medication use at last follow-up was also comparable
 </span></p><h2><span class="labels">Interventions</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Transvenous defibrillator implantation in the intervention group
- Standard medical treatment in the control group
 </span></p><h2><span class="labels">Outcomes</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Primary Outcome
- 19.8% mortality in conventional therapy group
- 14.2% mortality in defibrillator group
- Hazard ratio for death: 0.69 (95% CI, 0.51 to 0.93; P=0.016)
 </span></p><h2><span class="labels">Criticisms</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- The incidence of heart failure requiring hospitalization was higher in the defibrillator group.
- The cost and resource implications of widespread prophylactic implantation are substantial.
 </span></p><h2><span class="labels">Funding</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">The study was supported by a research grant from Guidant to the University of Rochester School of Medicine and Dentistry. Some authors disclosed financial relationships with Guidant.
 </span></p><h2><span class="labels">Further Reading</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">The trial publication and relevant additional literature involve advancements in the field of cardiac electrophysiology and criteria for defibrillator implantation post-MI. </span></p>    	
        <div class="footer">Footer</div>
        </body>
        </html>